Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
2011 February 1
Main Authors: | Lander, Eric S. (Contributor), Meyerson, Matthew L. (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology (Contributor), Mermel, Craig H. (Contributor) |
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group,
2012-10-17T14:54:12Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Identification of subtype-specific pathogenetic aberrations in soft tissue sarcoma utilising high-resolution genomic copy number analysis
by: Salawu, Abdulazeez
Published: (2014) -
Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas
by: Jun Wang, et al.
Published: (2021-01-01) -
Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
by: Xin-Hui Du, et al.
Published: (2020-09-01) -
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
by: Kenji Nakano, et al.
Published: (2018-03-01) -
Targeted therapy for soft tissue sarcomas in adolescents and young adults
by: Steppan DA, et al.
Published: (2017-03-01)